Gamma-hydroxybutyrate, gamma-butyrolactone, and 1,4-butanediol: A case report and review of the literature

被引:55
作者
Shannon, M [1 ]
Quang, LS [1 ]
机构
[1] Massachusetts Rhode Isl Reg Ctr Poison Control &, Program Clin Pharmacol Toxicol, Boston, MA USA
关键词
gamma-hydroxybutyrate; gamma-butyrolactone; 1,4-butanediol; toxicology review;
D O I
10.1097/00006565-200012000-00017
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
GHB, GBL, and 1,4-BD are prevalent drugs of abuse in the United States. Unfortunately, attempts to regulate GHB have been circumvented by clandestine trafficking through the Internet and marketing of 'natural' chemical precursors. Despite repeated FDA warnings to the public about their dangers as well as recent federal scheduling of GHB and GBL, they remain accessible as 'club drugs' on Internet websites, as natural dietary supplements in health food stores, and as illicit products manufactured at home or in clandesetine laboratories. EDs and poison control centers nationwide will undoubtedly continue to manage GHB, GBL, and 1,4-BD toxicities.
引用
收藏
页码:435 / 440
页数:6
相关论文
共 55 条
[12]  
DYER JE, 1999, POISONING DRUG OVERD, P179
[13]   EEG CHANGES DURING SEDATION WITH GAMMA-HYDROXYBUTYRIC ACID [J].
ENTHOLZNER, E ;
MIELKE, L ;
PICHLMEIER, R ;
WEBER, F ;
SCHNECK, H .
ANAESTHESIST, 1995, 44 (05) :345-350
[14]  
Fieler EL, 1998, CLIN CHEM, V44, P692
[15]  
*FOOD DRUG ADM, FDA TALK PAP FDA WAR
[16]  
*FOOD DRUG ADM, MEDW MOR GBL GHB BD
[17]  
FRIEDMAN J, 1996, NEUROLOGY, V47, P1351
[18]  
GALLOWAY GP, 1997, ADDICTION, V92, P82
[19]  
Garrison G., 1998, Journal of Toxicology Clinical Toxicology, V36, P503
[20]  
Greene T., 1999, Journal of Toxicology Clinical Toxicology, V37, P651